Yes and no.With a PE below 5, no debt, and cash equaling 1/3 of market cap it doesn't take much to make this thing a good value.Margins are up and their bio-science sector seems to be increasing.Doesn't take much more than that to make me happy with the chip industry in its current funk.Expect their sales and profits to diminish through next year, then to grow after that. With these numbers, that is enough.
Bad quarter, reduced guidance, bad visibility. Probably $7.50-$8.00 by next week as it resumes its downtrend.
These guys are very negative on the conference call. I dont care if the numbers are bad at least pretend to seem optimistic.